ArtusLabs and Viamet Pharmaceuticals Collaborate to Develop Metallobase™

ArtusLabs, Inc. (www.artuslabs.com), the leader in scientifically-aware data management systems, and Viamet Pharmaceuticals, Inc. (www.viamet.com), a human therapeutic company focused on “best-in-class” metalloenzyme inhibitors, today announced the collaborative development of Metallobase™, Viamet Pharmaceuticals’ proprietary database of metalloenzymes and metalloenzyme inhibitors.

“ArtusLabs was the perfect choice to help us develop this critical system for our internal discovery efforts. Their in-house technical expertise in chemistry-oriented solutions and drug discovery awareness were the skills that we were looking for in a data management partner,” said Dr. Robert Schotzinger, President & CEO of Viamet Pharmaceuticals.

Utilizing their flagship product, Ensemble for Life Science™, ArtusLabs created a system that combines access of structured, database-driven data with unstructured data in the same environment. “To capture Viamet’s unstructured data, we utilized Ensemble’s powerful functionality as a module to the custom database developed for Viamet. This allowed us to rapidly and cost-effectively connect the structured search functionality of Viamet’s proprietary Metallobase™ with their unstructured data,” states Robin Smith, CEO of ArtusLabs. Ensemble is a system that blends data management, data mining, workplace collaboration and personal publication into one web-deployed system.

About ArtusLabs, Inc.

ArtusLabs is paving the way in developing web-enabled technologies for the life science industry by striving to help their customers save time, reduce infrastructure costs, and increase organization’s information retention. ArtusLabs products and services are tuned to meet the needs of today’s scientific organization. To learn more about ArtusLabs, Inc., please visit: www.artuslabs.com.

Robin Smith, CEO and Co-Founder of ArtusLabs will be speaking at the Southeast Venture Conference in Atlanta, GA March 11-12, 2009. To learn more, go to http://www.seventure.org/featured_cos.html.

About Viamet Pharmaceuticals, Inc.

Viamet Pharmaceuticals, Inc. has assembled a world-class team that comprises expertise in both bioinorganic chemistry and drug discovery and development. Viamet discovers and develops “best-in-class” small-molecule inhibitors of validated metalloenzymes via an innovative and proprietary metal-binding approach, the Metallophile™ Technology. www.viamet.com

< | >